| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Fátima Gärtner | |
| Nuno Vale | |||
| Maria João Gouveia | |||
| P2860 | cites work | Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis | Q21560762 |
| Schistosomiasis vaccines | Q24598949 | ||
| The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer | Q24612587 | ||
| Helminth infections: the great neglected tropical diseases | Q24648324 | ||
| Food-borne trematodiases | Q24650873 | ||
| The treatment of experimental schistosomiasis with a combination of oxamniquine and praziquantel | Q71221403 | ||
| Combination antiretroviral therapy for HIV infection | Q74685124 | ||
| Schistosome resistance to praziquantel | Q80098643 | ||
| Studies on parasitologic and haematologic activities of an enaminone derivative of 4-hydroxyquinolin-2(1H)-one against murine schistosomiasis mansoni | Q80161238 | ||
| Is actin the praziquantel receptor? | Q80584028 | ||
| Therapeutic effects of Allium sativum and Allium cepa in Schistosoma mansoni experimental infection | Q84556558 | ||
| Silymarin treatment reduces granuloma and hepatic fibrosis in experimental schistosomiasis | Q84700726 | ||
| Comparative in vivo antioxidant levels in Schistosoma mansoni infected mice treated with praziquantel or the essential oil of Melaleuca armillaris leaves | Q86663950 | ||
| The antioxidants resveratrol and N-acetylcysteine enhance anthelmintic activity of praziquantel and artesunate against Schistosoma mansoni | Q92912352 | ||
| Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention | Q26765412 | ||
| Repurposing drugs for the treatment and control of helminth infections | Q26823355 | ||
| Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer | Q27008499 | ||
| The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity | Q27021258 | ||
| Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel | Q27304398 | ||
| Serotonin signaling in Schistosoma mansoni: a serotonin-activated G protein-coupled receptor controls parasite movement | Q27331388 | ||
| Schistosomiasis | Q28215200 | ||
| The current status of opisthorchiasis and clonorchiasis in the Mekong Basin | Q28247216 | ||
| Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases | Q28273898 | ||
| The global health burden of infection-associated cancers in the year 2002 | Q28290871 | ||
| Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial | Q28299316 | ||
| Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis | Q28539314 | ||
| Functional Analysis of the Unique Cytochrome P450 of the Liver Fluke Opisthorchis felineus | Q28551200 | ||
| Curcumin Generates Oxidative Stress and Induces Apoptosis in Adult Schistosoma mansoni Worms | Q28553673 | ||
| Control of neglected tropical diseases | Q29547285 | ||
| Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis | Q29619819 | ||
| Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa | Q29620602 | ||
| Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice | Q30485364 | ||
| Experimental schistosomiasis mansoni: modulation of granulomas by inhibition of collagen cross-link formation. Preliminary report | Q31158829 | ||
| Opisthorchis viverrini infection: pathogenesis and clinical features | Q33481513 | ||
| An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response | Q33853821 | ||
| Relationship between schistosomiasis and bladder cancer | Q33975409 | ||
| Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China | Q34404489 | ||
| Human schistosomiasis | Q34413522 | ||
| Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention | Q34521885 | ||
| Epidemiology of cholangiocarcinoma: an update focusing on risk factors. | Q34615924 | ||
| Clinical diagnosis and staging of cholangiocarcinoma | Q34631337 | ||
| P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection. | Q34680930 | ||
| Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers | Q34763466 | ||
| Opisthorchis viverrini: an underestimated parasite in world health | Q34859666 | ||
| Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. | Q34909875 | ||
| Synergy of concurrent low dose oxamniquine and praziquantel in schistosomiasis | Q34995195 | ||
| Opisthorchiasis: an overlooked danger | Q35250836 | ||
| Drugs for the control of parasitic diseases: current status and development in schistosomiasis | Q35569078 | ||
| Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer | Q35580183 | ||
| The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer. | Q39201937 | ||
| Effect of Opisthorchis felineus infection and dimethylnitrosamine administration on the induction of cholangiocarcinoma in Syrian hamsters | Q39207209 | ||
| Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni | Q39237134 | ||
| Advancing a vaccine to prevent human schistosomiasis | Q39246394 | ||
| Introgressive hybridizations of Schistosoma haematobium by Schistosoma bovis at the origin of the first case report of schistosomiasis in Corsica (France, Europe). | Q39264935 | ||
| Schistosoma mansoni: in vitro schistosomicidal activity of essential oil of Baccharis trimera (less) DC. | Q39318216 | ||
| Efficacy and Safety of Praziquantel Against Light Infections of Opisthorchis viverrini: A Randomized Parallel Single-Blind Dose-Ranging Trial | Q39434093 | ||
| Little effect of praziquantel or artemisinin on clonorchiasis in Northern Vietnam. A pilot study | Q39525550 | ||
| Infection with Opisthorchis felineus induces intraepithelial neoplasia of the biliary tract in a rodent model. | Q40045755 | ||
| Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem | Q40076769 | ||
| Large outbreak of urogenital schistosomiasis acquired in Southern Corsica, France: monitoring early signs of endemicization? | Q40137709 | ||
| Anthelmintic activity of cytochrome P450 inhibitors miconazole and clotrimazole: in-vitro effect on the liver fluke Opisthorchis felineus. | Q40205052 | ||
| In vivo and in vitro activity of oil extract of garlic (Allium sativum Linnaeus) against Schistosoma japonicum cercariae | Q40284457 | ||
| Mechanisms of chemical carcinogenesis | Q40307223 | ||
| Resveratrol ameliorates oxidative stress and organ dysfunction in Schistosoma mansoni infected mice | Q40342929 | ||
| Immunomodulatory effect of garlic oil extract on Schistosoma mansoni infected mice. | Q40856555 | ||
| The first comprehensive study of praziquantel effects in vivo and in vitro on European liver fluke Opisthorchis felineus (Trematoda). | Q41344364 | ||
| Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis | Q42239154 | ||
| Schistosoma mansoni: N-acetylcysteine downregulates oxidative stress and enhances the antischistosomal activity of artemether in mice. | Q42745282 | ||
| Curcumin induces a nuclear factor-erythroid 2-related factor 2-driven response against oxidative and nitrative stress after praziquantel treatment in liver fluke-infected hamsters | Q42755736 | ||
| Schistosomiasis haematobium, Corsica, France | Q42920057 | ||
| Protective effect of melatonin against Opisthorchis viverrini-induced oxidative and nitrosative DNA damage and liver injury in hamsters | Q42971839 | ||
| Clinical manifestation of opisthorchiasis and treatment | Q35581350 | ||
| Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control | Q35680581 | ||
| Chemotherapy for major food-borne trematodes: a review | Q35841575 | ||
| Are Ca2+ channels targets of praziquantel action? | Q35993816 | ||
| Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa | Q36201850 | ||
| Artemisinin-based combinations | Q36300935 | ||
| Multicentre trials of praziquantel in human schistosomiasis: design and techniques | Q36675102 | ||
| MCR synthesis of praziquantel derivatives | Q37017439 | ||
| Carcinogenic liver fluke Opisthorchis viverrini oxysterols detected by LC-MS/MS survey of soluble fraction parasite extract. | Q37230992 | ||
| Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis | Q37315241 | ||
| Schistosoma genomics: new perspectives on schistosome biology and host-parasite interaction. | Q37561082 | ||
| Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application | Q37700067 | ||
| The Digenea parasite Opisthorchis felineus: a target for the discovery and development of novel drugs | Q37779325 | ||
| Mechanisms linking pathogens-associated inflammation and cancer | Q37811164 | ||
| Drug repositioning: re-investigating existing drugs for new therapeutic indications | Q37886513 | ||
| Susceptibility or resistance of praziquantel in human schistosomiasis: a review | Q38050973 | ||
| Ca²⁺ channels and praziquantel: a view from the free world | Q38067995 | ||
| Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery | Q38116989 | ||
| The zoonotic, fish-borne liver flukes Clonorchis sinensis, Opisthorchis felineus and Opisthorchis viverrini | Q38131636 | ||
| Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta-analysis | Q38174667 | ||
| The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer). | Q38175909 | ||
| Malaria medicines: a glass half full? | Q38497838 | ||
| The liver fluke Opisthorchis felineus: biology, epidemiology and carcinogenic potential. | Q38689099 | ||
| Efficacy and safety of tribendimidine against Opisthorchis viverrini: two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials | Q38836395 | ||
| Schistosomiasis reaches Europe. | Q38913455 | ||
| Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters | Q38945718 | ||
| Melatonin reduces oxidative damage and increases survival of mice infected with Schistosoma mansoni | Q38990123 | ||
| Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer. | Q39030300 | ||
| Activity of tribendimidine and praziquantel combination therapy against the liver fluke Opisthorchis viverrini in vitro and in vivo | Q39126543 | ||
| Dose-response relationships and tegumental surface alterations in Opisthorchis viverrini following treatment with mefloquine in vivo and in vitro | Q39126638 | ||
| Opisthorchis viverrini: efficacy and tegumental alterations following administration of tribendimidine in vivo and in vitro | Q39126651 | ||
| Effect of artesunate and artemether against Clonorchis sinensis and Opisthorchis viverrini in rodent models | Q39126708 | ||
| Biliary parasites: diagnostic and therapeutic strategies | Q39132719 | ||
| Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance. | Q39164325 | ||
| Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment | Q43085099 | ||
| Curcumin reduces oxidative and nitrative DNA damage through balancing of oxidant-antioxidant status in hamsters infected with Opisthorchis viverrini | Q43276729 | ||
| The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice | Q43823575 | ||
| Lifting the burden of schistosomiasis--defining elements of infection-associated disease and the benefits of antiparasite treatment | Q43932584 | ||
| Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis | Q44012685 | ||
| Tumour-like phenotypes in urothelial cells after exposure to antigens from eggs of Schistosoma haematobium: an oestrogen-DNA adducts mediated pathway? | Q44401961 | ||
| Antioxidant and schistosomicidal effect of Allium sativum and Allium cepa against Schistosoma mansoni different stages. | Q44405662 | ||
| Treatment of acute schistosomiasis mansoni with praziquantel and an antifibrotic agent in mice. Maintenance of resistance to infection | Q44519846 | ||
| Immunohistopathological changes in murine Schistosomiasis mansoni under the influence of N-acetyl-L-cysteine | Q44540218 | ||
| Sequence and level of endogenous expression of calcium channel beta subunits in Schistosoma mansoni displaying different susceptibilities to praziquantel | Q44567644 | ||
| Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase | Q44704982 | ||
| Antischistosomal action of atorvastatin alone and concurrently with medroxyprogesterone acetate on Schistosoma haematobium harboured in hamster: surface ultrastructure and parasitological study. | Q45181572 | ||
| Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection | Q45252224 | ||
| Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni | Q46106188 | ||
| The effect of antioxidant properties of aqueous garlic extract and Nigella sativa as anti-schistosomiasis agents in mice. | Q46125970 | ||
| Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. | Q46232265 | ||
| The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand | Q46247381 | ||
| Praziquantel binds Schistosoma mansoni adult worm actin. | Q46531951 | ||
| Association of bacteriuria and urinary nitrosamine formation with Schistosoma haematobium infection in the Qalyub area of Egypt | Q46588611 | ||
| Sativa seeds against Schistosoma mansoni different stages | Q46602116 | ||
| Melatonin inhibits cholangiocarcinoma and reduces liver injury in Opisthorchis viverrini-infected and N-nitrosodimethylamine-treated hamsters | Q46641268 | ||
| Schistosoma mansoni: melatonin enhances efficacy of cercarial and soluble worm antigens in the induction of protective immunity against infection in the hamster. | Q46709287 | ||
| Effect of combined low dose praziquantel and oxamniquine on different stages of schistosome maturity | Q46915902 | ||
| Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice. | Q46973118 | ||
| Cytochrome P450 in fluke Opisthorchis felineus: identification and characterization. | Q48054293 | ||
| Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis | Q49627930 | ||
| Melatonin suppresses eosinophils and Th17 cells in hamsters treated with a combination of human liver fluke infection and a chemical carcinogen | Q50054446 | ||
| Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment. | Q50738323 | ||
| Economic effects of echinococcosis in a disease-endemic region of the Tibetan Plateau. | Q50765007 | ||
| Schistosomiasis therapeutics: whats in the pipeline? | Q50966400 | ||
| A Physicochemical and Pharmacological Study of the Newly Synthesized Complex of Albendazole and the Polysaccharide Arabinogalactan from Larch Wood. | Q51743025 | ||
| A combination of praziquantel and the traditional medicinal plant Thunbergia laurifolia on Opisthorchis viverrini infection and cholangiocarcinoma in a hamster model. | Q51751782 | ||
| Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasis. | Q51760961 | ||
| Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice. | Q52672813 | ||
| Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules. | Q52699502 | ||
| Promotion of cholangiocarcinogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation. | Q53477305 | ||
| Enhancement of DHPN induced hepatocellular, cholangiocellular and pancreatic carcinogenesis by Opisthorchis viverrini infestation in Syrian golden hamsters. | Q53522147 | ||
| Haematuria and proteinuria during Schistosoma haematobium infection: relationship to intensity of infection and the value of chemical reagent strips for pre- and post-treatment diagnosis. | Q53883406 | ||
| Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren. | Q53888452 | ||
| Praziquantel: is there real resistance and are there alternatives? | Q53973326 | ||
| A comparative study of the reproductive system of mature, immature and "unisexual" female Schistosoma mansoni. | Q54162318 | ||
| Effects of miconazole/clotrimazole and praziquantel combinations against the liver fluke Opisthorchis felineus in vivo and in vitro | Q57116125 | ||
| The anti-schistosomal drug praziquantel is an adenosine antagonist | Q58070149 | ||
| A New Series of 2-Aminomethyltetrahydroquinoline Derivatives displaying Schistosomicidal Activity in Rodents and Primates | Q59057898 | ||
| Pooled Population Pharmacokinetic Analysis of Tribendimidine for the Treatment of Infections | Q64110164 | ||
| Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite | Q67984511 | ||
| Multistage carcinogenesis of liver-fluke-associated cholangiocarcinoma in Thailand | Q68283660 | ||
| Albendazole in the treatment of opisthorchiasis and concomitant intestinal helminthic infections | Q70365444 | ||
| Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel | Q71108967 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P433 | issue | 3 | |
| P577 | publication date | 2020-02-25 | |
| P1433 | published in | Biomolecules | Q23929963 |
| P1476 | title | Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with Drugs | |
| P478 | volume | 10 |
Search more.